Cargando…

Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy

BACKGROUND: Cancer Associated Macrophage-Like cells (CAMLs) are polynucleated circulating stromal cells found in the bloodstream of numerous solid-tumor malignancies. Variations within CAML size have been associated with poorer progression free survival (PFS) and overall survival (OS) in a variety o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gironda, Daniel J., Adams, Daniel L., He, Jianzhong, Xu, Ting, Gao, Hui, Qiao, Yawei, Komaki, Ritsuko, Reuben, James M., Liao, Zhongxing, Blum-Murphy, Mariela, Hofstetter, Wayne L., Tang, Cha-Mei, Lin, Steven H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640696/ https://www.ncbi.nlm.nih.gov/pubmed/33148307 http://dx.doi.org/10.1186/s12967-020-02563-x

Ejemplares similares

Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study
por: Shi, Anhui, et al.
Publicado: (2017)

Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma
por: He, Li-Ru, et al.
Publicado: (2015)

Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer
por: Yue, Jinbo, et al.
Publicado: (2017)

Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings
por: Gironda, Daniel J., et al.
Publicado: (2023)

Achalasia Combined with Esophageal Cancer Treated by Concurrent Chemoradiation Therapy
por: Park, Jun Chul, et al.
Publicado: (2009)

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients
por: Warnecke-Eberz, Ute, et al.
Publicado: (2020)

The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer
por: Chin, Alexander L., et al.
Publicado: (2018)

Chemoradiation for elderly patients (≥ 65 years) with esophageal cancer: a retrospective single-center analysis
por: Linde, Philipp, et al.
Publicado: (2022)

Postoperative Radiation Therapy for Non-Small Cell Lung Cancer and Thymic Malignancies
por: Gomez, Daniel R., et al.
Publicado: (2012)

Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal Cancer
por: Gaber, Charles E, et al.
Publicado: (2022)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2015)

Chemoradiation as a nonsurgical treatment option for early-stage esophageal cancers: a retrospective cohort study
por: Pathak, Ranjan, et al.
Publicado: (2021)

A Case of Recurrent Esophageal Cancer Treated with Concurrent Chemoradiation Therapy in Pregnancy
por: Yamada, Kaori, et al.
Publicado: (2018)

Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
por: Triantafyllou, Tania, et al.
Publicado: (2020)

A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma
por: Skinner, Heath D, et al.
Publicado: (2014)

Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review
por: Rahimy, Elham, et al.
Publicado: (2020)

Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma
por: Deng, Wei, et al.
Publicado: (2020)

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2019)

Monitoring PD-L1 Expression on Circulating Tumor–Associated Cells in Recurrent Metastatic Non–Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy
por: Moran, Jillian A., et al.
Publicado: (2022)

Long-term survival after concurrent chemoradiation therapy for esophageal cancer with tracheal invasion
por: Cho, Joon Hyun, et al.
Publicado: (2015)

Concurrent chemoradiation therapy tailored to the older adults with esophageal cancer: state of the art and the future
por: Song, Tao, et al.
Publicado: (2018)

Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2017)

Handgrip Strength Is Associated With Treatment Modifications During Neoadjuvant Chemoradiation in Patients With Esophageal Cancer
por: Lakenman, Patty, et al.
Publicado: (2017)

Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative Intent
por: Søndergaard, Mette Marie A., et al.
Publicado: (2021)

DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation
por: Macedo‐Silva, Catarina, et al.
Publicado: (2023)

Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomy
por: Potdar, Ankit, et al.
Publicado: (2023)

CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer
por: Gardner, Kirby P., et al.
Publicado: (2022)

Influence of Caregiver Presence During Physician Office Visits on Patients Undergoing Chemoradiation Therapy for Esophageal Cancer
por: Ho, Joseph K., et al.
Publicado: (2021)

Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
por: Dings, Mark P.G., et al.
Publicado: (2022)

Treatment of Brain Metastasis from Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2010)

Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients
por: Lopez, Anthony, et al.
Publicado: (2020)

What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2013)

Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer()
por: Warren, Samantha, et al.
Publicado: (2014)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
por: Warren, Samantha, et al.
Publicado: (2017)

Cardiomyocyte-specific circulating cell-free methylated DNA in esophageal cancer patients treated with chemoradiation
por: Roth, Sarah Martinez, et al.
Publicado: (2021)

Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
por: Rizzo, Alessandro
Publicado: (2022)

Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2012)

Concurrent Chemoradiation for Vaginal Cancer
por: Miyamoto, David T., et al.
Publicado: (2013)

Reducing prolonged chemoradiation treatment times for cervical cancer
por: Vitzthum, Lucas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1ldlr288h6r9cptunl7uvinc8j